Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)
| 1.23 Delayed Data As of Aug 05 |  +0.04 / +3.39%Today’s Change | 0.84 Today|||52-Week Range 4.67 | -57.47% Year-to-Date |
Latest ZYNE News | Press Releases
No recent news for Zynerba Pharmaceuticals Inc.
Today’s Trading
| Previous close | 1.18 |
| Today’s open | 1.19 |
| Day’s range | 1.17 - 1.27 |
| Volume | 532,941 |
| Average volume (3 months) | 463,514 |
| Market cap | $43.5M |
Data as of 4:03pm ET, 08/05/2022
Growth & Valuation
| Earnings growth (last year) | +49.98% |
| Earnings growth (this year) | +1.89% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.56 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| APMAptorum Group Ltd | -0.01 | -0.65% |
| NOVNNovan Inc | +0.12 | +4.38% |
| ADMPAdamis Pharmaceutica... | -0.01 | -1.76% |
| --Abliva AB | 0.00 | 0.00% |
Data as of 4:03pm ET, 08/05/2022
Financials
| Last reporting date | August 5, 2022 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$37.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Devon, Pennsylvania |
Forecasts
